Greenwood Capital Associates LLC Buys Shares of 1,750 Encompass Health Corporation $EHC

Greenwood Capital Associates LLC purchased a new stake in Encompass Health Corporation (NYSE:EHC) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,750 shares of the company’s stock, valued at approximately $215,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. WPG Advisers LLC acquired a new position in shares of Encompass Health in the 1st quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after purchasing an additional 367 shares during the period. Park Place Capital Corp acquired a new position in shares of Encompass Health in the 2nd quarter valued at $72,000. Arlington Trust Co LLC boosted its position in shares of Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after purchasing an additional 125 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its position in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after purchasing an additional 115 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Down 0.3%

EHC opened at $123.13 on Friday. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.86. The business has a 50-day moving average of $121.25 and a 200-day moving average of $115.55. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market capitalization of $12.40 billion, a PE ratio of 24.10, a price-to-earnings-growth ratio of 2.16 and a beta of 0.93.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business earned $1.11 EPS. The business’s quarterly revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. Encompass Health’s dividend payout ratio (DPR) is 14.87%.

Insider Buying and Selling at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on EHC. Wall Street Zen lowered Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. Truist Financial raised their price objective on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. KeyCorp raised their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Bank of America raised their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $139.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.